Vanda Pharmaceuticals to Announce Second Quarter 2008 Financial Results on August 5, 2008
01 8월 2008 - 2:46AM
PR Newswire (US)
Conference Call and Webcast to Follow ROCKVILLE, Md., July 31
/PRNewswire-FirstCall/ -- Vanda Pharmaceuticals Inc. (NASDAQ:VNDA),
a biopharmaceutical company focused on the development and
commercialization of clinical-stage product candidates for central
nervous system disorders, today announced it will release results
for the second quarter ended June 30, 2008, on Tuesday, August 5,
2008, before the market opens. A full text copy of the release will
be disseminated at that time. Mihael H. Polymeropoulos, M.D.,
President and Chief Executive Officer, will host a conference call
to discuss the results and other corporate developments at 10:30 AM
ET on Tuesday, August 5, 2008. Also participating on the call will
be Steven A. Shallcross, Senior Vice President and CFO. To
participate in the conference call, dial the appropriate number
below shortly before the 10:30 AM start time and ask for the Vanda
Pharmaceuticals conference call hosted by Dr. Polymeropoulos. The
teleconference dial-in numbers are as follows: Domestic callers
1-800-259-0251 International callers 1-617-614-3671 The conference
call will be broadcast simultaneously and archived on the company's
Web site, http://www.vandapharma.com/ . Investors should go to the
Web site at least 15 minutes early to register, download, and
install any necessary audio software. A replay of the call will be
available on Tuesday, August 5, 2008, beginning at 12:30 PM ET and
will be accessible until Thursday, September 4, 2008, at 5:00 PM
ET. The replay call-in number is 1-888-286-8010 for domestic
callers and 1-617-801-6888 for international callers. The access
number is 98529573. About Vanda Pharmaceuticals Inc.: Vanda
Pharmaceuticals Inc. is a biopharmaceutical company focused on the
development and commercialization of clinical-stage product
candidates for central nervous system disorders. For more on Vanda
Pharmaceuticals Inc., please visit http://www.vandapharma.com/ .
DATASOURCE: Vanda Pharmaceuticals Inc. CONTACT: Steven A.
Shallcross, Senior Vice President & CFO of Vanda
Pharmaceuticals Inc., +1-240-599-4500, Web site:
http://www.vandapharma.com/
Copyright
Vanda Pharmaceuticals (NASDAQ:VNDA)
과거 데이터 주식 차트
부터 9월(9) 2024 으로 10월(10) 2024
Vanda Pharmaceuticals (NASDAQ:VNDA)
과거 데이터 주식 차트
부터 10월(10) 2023 으로 10월(10) 2024